Philips Unveils AI DeviceGuide, Samsung Acquires Xealth, and Deloitte's $168B AI Insight - Life AI Weekly #43

Hi there,

In this edition of Life AI Weekly, we're diving into the latest developments in the healthcare and life sciences sectors, where artificial intelligence is making significant strides. Function Health has secured a substantial $298 million in funding and is launching an AI lab, aiming to revolutionize healthcare solutions. Meanwhile, OpenAI is investing in Red Queen Bio to enhance AI biosecurity, highlighting the growing importance of AI in safeguarding health data.

Additionally, Hyland and Tribun Health are collaborating to integrate AI into pathology, and a notable 73% of pharmaceutical companies are now engaging with agentic AI, showcasing the technology's expanding role in drug discovery. These stories underscore the transformative impact of AI across various facets of healthcare and life sciences, promising advancements in diagnostics, patient care, and data security.

The Health Sector Coordinating Council is set to release guidance documents to address AI-related cybersecurity risks in healthcare, focusing on education and secure design principles. Meanwhile, Function Health has raised $298 million in Series B funding and launched the Medical Intelligence Lab to advance AI for personalized health insights.

Function Health has secured $298 million in funding and launched an AI lab, while OpenAI has invested in Red Queen Bio to enhance AI biosecurity capabilities. These developments highlight the growing intersection of AI and healthcare innovation.

Hyland and Tribun Health have partnered to enhance digital pathology workflows by integrating Tribun Health's platform with Hyland's imaging solutions, aiming to improve diagnostics and patient outcomes globally.
MIT Technology Review Insights and Globant report that 73% of pharmaceutical organizations are involved in agentic AI initiatives, focusing on regulatory compliance, data standardization, patient support, and market intelligence.

Pacific Software Inc. has announced a strategic partnership with SpectroChip Global Inc. to develop AI-driven precision diagnostics, following its acquisition of PurMinds NeuroPharma. Meanwhile, Philips has launched DeviceGuide, an AI tool designed to enhance heart valve repair procedures by improving real-time 3D navigation and visualization.